Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Declines By 74.5%

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 87,719 shares, a drop of 74.5% from the August 15th total of 344,075 shares. Currently, 10.8% of the shares of the company are sold short. Based on an average daily trading volume, of 212,831 shares, the days-to-cover ratio is currently 0.4 days.

Analysts Set New Price Targets

A number of brokerages recently issued reports on FEED. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of Nanovibronix in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

Insider Transactions at Nanovibronix

In other Nanovibronix news, insider Christian Michael Glibert sold 17,500 shares of Nanovibronix stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $8.28, for a total value of $144,900.00. The sale was disclosed in a filing with the SEC, which is available through this link. 12.20% of the stock is owned by company insiders.

Nanovibronix Stock Up 0.3%

Nanovibronix stock traded up $0.01 during trading hours on Friday, hitting $3.58. The stock had a trading volume of 10,931 shares, compared to its average volume of 54,630. The company has a 50-day moving average of $4.69 and a two-hundred day moving average of $12.26. Nanovibronix has a fifty-two week low of $3.48 and a fifty-two week high of $208.80. The company has a market cap of $3.29 million, a PE ratio of -0.03 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last announced its quarterly earnings data on Monday, August 17th. The company reported ($23.76) earnings per share for the quarter. The firm had revenue of $0.24 million for the quarter. Nanovibronix had a negative return on equity of 60.73% and a negative net margin of 1,093.61%.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non?invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low?intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound?care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound?care clinics, long?term care facilities and patients requiring home?based therapies.